|
Market Closed -
NYSE
01:30:02 21/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 65.22 USD | +0.11% |
|
+3.61% | -0.28% |
| 08:47pm | Unilever to sell bandage brand Welly Health for undisclosed sum | AN |
| 06:32pm | The Dip That Keeps On Dipping |  |
Company Valuation: Unilever PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,20,277 | 1,19,234 | 1,09,432 | 1,36,147 | 1,21,203 | 1,25,725 | - | - |
| Change | - | -0.87% | -8.22% | 24.41% | -10.98% | 3.73% | - | - |
| Enterprise Value (EV) 1 | 1,45,787 | 1,42,910 | 1,33,089 | 1,60,666 | 1,44,279 | 1,49,563 | 1,48,487 | 1,47,695 |
| Change | - | -1.97% | -6.87% | 20.72% | -10.2% | 3.66% | -0.72% | -0.53% |
| P/E | 20.2x | 15.8x | 17.1x | 24x | 21.5x | 19.5x | 18x | 17x |
| PBR | 7.03x | 6.27x | 6.05x | 6.81x | 7.82x | 7.91x | 7.27x | 6.64x |
| PEG | - | 0.5x | -1.2x | -2.3x | 40.28x | 1.2x | 2.31x | 2.8x |
| Capitalization / Revenue | 2.29x | 1.98x | 1.84x | 2.24x | 2.4x | 2.43x | 2.33x | 2.25x |
| EV / Revenue | 2.78x | 2.38x | 2.23x | 2.64x | 2.86x | 2.89x | 2.75x | 2.64x |
| EV / EBITDA | 12.8x | 12.5x | 11.6x | 12.5x | 12.7x | 12.7x | 12x | 11.5x |
| EV / EBIT | 15.1x | 14.8x | 13.4x | 14.4x | 14.3x | 14.4x | 13.6x | 12.9x |
| EV / FCF | 22.8x | 25.3x | 18.8x | 23.2x | 24.4x | 23.5x | 21.1x | 20.3x |
| FCF Yield | 4.39% | 3.96% | 5.33% | 4.31% | 4.1% | 4.25% | 4.73% | 4.93% |
| Dividend per Share 2 | 1.954 | 1.883 | 1.921 | 1.979 | 1.82 | 1.895 | 1.989 | 2.093 |
| Rate of return | 3.7% | 3.55% | 3.9% | 3.2% | 3.27% | 3.24% | 3.41% | 3.58% |
| EPS 2 | 2.61 | 3.364 | 2.88 | 2.576 | 2.59 | 3.001 | 3.235 | 3.431 |
| Distribution rate | 74.8% | 56% | 66.7% | 76.8% | 70.3% | 63.1% | 61.5% | 61% |
| Net sales 1 | 52,444 | 60,073 | 59,604 | 60,761 | 50,503 | 51,739 | 53,905 | 55,840 |
| EBITDA 1 | 11,382 | 11,408 | 11,510 | 12,803 | 11,394 | 11,732 | 12,331 | 12,872 |
| EBIT 1 | 9,636 | 9,683 | 9,931 | 11,179 | 10,084 | 10,394 | 10,933 | 11,436 |
| Net income 1 | 6,049 | 7,642 | 6,487 | 5,744 | 9,469 | 6,493 | 6,685 | 7,286 |
| Net Debt 1 | 25,510 | 23,676 | 23,657 | 24,519 | 23,076 | 23,838 | 22,762 | 21,970 |
| Reference price 2 | 52.85 | 53.04 | 49.26 | 61.87 | 55.70 | 58.39 | 58.39 | 58.39 |
| Nbr of stocks (in thousands) | 22,75,903 | 22,47,919 | 22,21,344 | 22,00,509 | 21,75,828 | 21,53,300 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.18x | 4.4x | 16.11x | 2.79% | 37TCr | |
| 30.95x | 4.75x | 19.65x | 1.92% | 24TCr | |
| 19.4x | 2.88x | 12.72x | 3.25% | 14TCr | |
| 25.75x | 3.78x | 15.93x | 2.3% | 7.44TCr | |
| 55.5x | 7.91x | 30.44x | 0.22% | 4.91TCr | |
| 38.43x | 6.19x | 26.9x | 2.43% | 4.59TCr | |
| 36.26x | 2.72x | 15.09x | 1.46% | 3.83TCr | |
| 19.88x | 2.78x | 11.59x | 4.47% | 3.62TCr | |
| 16.08x | 2.41x | 11.19x | 4.89% | 3.51TCr | |
| Average | 29.49x | 4.20x | 17.74x | 2.64% | 11.41TCr | |
| Weighted average by Cap. | 27.03x | 4.29x | 17.27x | 2.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ULVR Stock
- UL Stock
- Valuation Unilever PLC
Select your edition
All financial news and data tailored to specific country editions
